Hepatitis C could be virtually eliminated by 2030, experts believe.

BMJ (Clinical research ed.)

Volumn 348, Issue , 2014, Pages

  Watts, Geoff ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 ((5 (2,4 DIOXO 3,4 DIHYDRO 2H PYRIMIDIN 1 YL) 4 FLUORO 3 HYDROXY 4 METHYLTETRAHYDROFURAN 2 YLMETHOXY)PHENOXYPHOSPHORYLAMINO)PROPIONIC ACID ISOPROPYL ESTER; 2-((5-(2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YLMETHOXY)PHENOXYPHOSPHORYLAMINO)PROPIONIC ACID ISOPROPYL ESTER; ANTIVIRUS AGENT; DRUG DERIVATIVE; URIDINE PHOSPHATE;

DISEASE ERADICATION; HEPATITIS C; HUMAN; METHODOLOGY; NOTE;

ANTIVIRAL AGENTS; DISEASE ERADICATION; HEPATITIS C; HUMANS; URIDINE MONOPHOSPHATE;

EID: 84901710118     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2700     Document Type: Note

References (0)